noom glp 1 program upgrades GLP-1 weight management app features as digital therapeutics gain US market traction Noom GLP-1 Companion

This is the third Drug Safety-related Labeling Change (SrLC) since December 19, 2025, for the drug, according to the FDAs label change database

The flip-top cap is produced via a blow-fill-seal process with distinct beveled edges

Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells

By augmenting tissue repair, increasing collagen synthesis, and mitigating inflammation, it serves as a multifaceted tool for promoting overall wellness and resilience

The neuroprotective mechanisms of action of GLP-1 and GLP-1RAs have provided a new perspective on potential therapeutic strategies for PD